IL6 and COVID-19: Biologic agents (anti-IL-1 and anti-IL-6 drugs) are used in the treatment of the severe manifestations of COVID-19 (10), and other anti-rheumatic drugs (including colchicine) have been proposed to prevent severe COVID-19 (11).